Pharmacokinetics and Excretion Studies on CDRI-85/92, an Antiulcer Proton Pump Inhibitor
CDRI 85/92 is an antiulcer pharmacophore and a proton pump inhibitor, which is in an advanced stage of preclinical trials. In view of its importance, pharmacokinetic and excretion were studied in Sprague Dawley rats after administering 20 mg/kg oral and intravenous doses. The compound was detectable...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Österreichische Apotheker-Verlagsgesellschaft
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293351/ |